Configuration of a scintillation proximity assay for the activity assessment of recombinant human adenine phosphoribosyltransferase.
Article Details
- CitationCopy to clipboard
Barrett C, Alley J, Pulido JC, Spurling H, Li P, Parsons T, Mallender WD, Bembenek ME
Configuration of a scintillation proximity assay for the activity assessment of recombinant human adenine phosphoribosyltransferase.
Assay Drug Dev Technol. 2006 Dec;4(6):661-9.
- PubMed ID
- 17199504 [ View in PubMed]
- Abstract
Adenine phosphoribosyltransferase plays a role in purine salvage by catalyzing the direct conversion of adenine to adenosine monophosphate. The involvement of the purine salvage pathway in tumor proliferation and angiogenesis makes adenine phosphoribosyltransferase a potential target for oncology drug discovery. We have expressed and characterized recombinant, N-terminally His-tagged human adenine phosphoribosyltransferase. Two assay formats were assessed for use in a high throughput screen: a spectrophotometric-based enzyme-coupled assay system and a radiometric ionic capture scintillation proximity bead assay format. Ultimately, the scintillation proximity assay format was chosen because of automated screening compatibility limitations of the coupled assay. We describe here the biochemical characterization of adenine phosphoribosyltransferase and the development of a robust, homogeneous, 384-well assay suitable for high throughput screening.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Adenine Adenine phosphoribosyltransferase Protein Humans UnknownNot Available Details - Drug Enzymes
Drug Enzyme Kind Organism Pharmacological Action Actions Adenosine phosphate Adenine phosphoribosyltransferase Protein Humans UnknownSubstrateDetails